
pmid: 8151403
handle: 20.500.14038/38345
Dipyridamole is a pharmacologic stressor used in place of exercise for myocardial perfusion imaging in patients who cannot exercise due to various physical limitations. Perfusion studies with dipyridamole can identify coronary artery disease (CAD) as accurately as maximal exercise stress testing. In addition, dipyridamole myocardial perfusion studies are useful to stratify patients according to risk of subsequent cardiac events. As dipyridamole is infused, it blocks the reabsorption and metabolism of adenosine normally produced in the body, producing the desired effect on the heart, coronary hyperemia. Dipyridamole can be used with 201Tl and 99mTc myocardial perfusion tracers, for either planar or SPECT imaging, in patients who cannot exercise or who can only exercise at submaximal levels.
Tomography, Emission-Computed, Single-Photon, Adenosine, Life Sciences, Coronary Disease, Heart, Dipyridamole, Sensitivity and Specificity, Thallium Radioisotopes, Medicine and Health Sciences, Humans, Emission-Computed, Tomography, Single-Photon
Tomography, Emission-Computed, Single-Photon, Adenosine, Life Sciences, Coronary Disease, Heart, Dipyridamole, Sensitivity and Specificity, Thallium Radioisotopes, Medicine and Health Sciences, Humans, Emission-Computed, Tomography, Single-Photon
| citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 26 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
